5/7/2025Early Clinical Data from China Show Promise for In Vivo CAR-T Therapie...

5/7/2025Everest Medicines Announces NMPA Full Approval of NEFECON

5/7/2025Novo Nordisk Sees Surge in China on Wegovy Launch, GLP-1 Momentum

5/7/2025Roche's Columvi Wins Expanded Approval in China for 2L+ DLBCL

5/7/2025CDE Publicizes the List of Reference Formulations for Generic Chemical...

5/7/2025CDE Seeks Comments on Draft Guidelines for Subject Selection in Bioequ...

5/6/2025China Announces Ambitious Plan to Optimize Primary Healthcare System b...

5/6/2025China Seeks Feedbacks on ICH Q1 Stability Testing Guideline Draft

5/6/2025China Seeks Feedbacks on Draft Guideline for Risk Management Plan Duri...

5/6/2025CStone Unveils Promising Preclinical Data for Trispecific Antibody CS2...

5/6/2025Kintor Reports Superior Hair Regrowth Results for KX-826 and Minoxidil...

5/6/2025China Approves Six Novel Drugs in April 2025, Marking Significant Adva...

5/6/2025Immunochina’s IM96 CAR-T Cell Therapy Wins FDA IND Clearance

5/5/2025China Introduces A New Regulatory Data Protection And Exclusivity Mech...

5/2/2025Recent Executive Moves

5/1/2025AstraZeneca Faces Escalating Legal Challenges in China Over Drug Impor...

5/1/2025CSL Reviews Potential China Tariff Relief for U.S.-Produced Albumin

5/1/2025China Accelerates Investment in Africa's Burgeoning Pharma Sector

5/1/2025D3 Bio Showcases Promising Next-Gen KRAS G12C Inhibitor at AACR and in...

5/1/2025Pharma's Crossroads: U.S. Investment Surges Under Trump, While China F...

4/30/2025BeiGene Secures Key Patent Victory in Brukinsa Dispute with AbbVie's P...

4/30/2025Escugen and ConjugateBio Announce Exclusive Option Agreement for EZWi-...

4/30/2025Sandoz and Henlius Collaborate to Broaden Oncology Treatment Options

4/29/2025Akeso's BsAb Shows Promising Survival Benefit in Lung Cancer Trial

4/29/2025Qyuns Sets Up Newco for Global Rights to Its Novel Long-Acting BsAb QX...

4/29/2025DualityBio and AstraZeneca Unite to Investigate Novel Lung Cancer Comb...

4/29/2025Innovent Initiates Global Phase 1 Trial for ADC IBI3020

4/29/20253SBio Advances Novel MUC17-Targeting Therapy SSS59 into Global Phase 1...

4/29/2025PegBio Poised for IPO on Hong Kong Stock Exchange Following Successful...

4/29/2025Ribo Life Science Files for IPO on HKSE, Backed by CICC and Citi

Page:38/801 Total number of articles:24019: [First][<<] [36] [37] [38] [39] [40] [>>] [End]